We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current NYXH market cap is 241.6M. The company's latest EPS is EUR -1.5077 and P/E is -5.37.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 1.11M | 976k | 1.82M | 1.22M | 771k |
| Operating Income | -17.19M | -10.99M | -10.84M | -12.21M | -13.31M |
| Net Income | -12.8M | -7.61M | -10.89M | -11.91M | -13.12M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 0 | 69k | 852k | 3.08M | 4.35M |
| Operating Income | -7.72M | -11.23M | -26.24M | -32.5M | -45.1M |
| Net Income | -8.45M | -12.25M | -27.62M | -31.23M | -43.21M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 142.41M | 134.6M | 124.16M | 113.02M | 148.23M |
| Total Liabilities | 26.84M | 26.06M | 26.14M | 25.82M | 28.09M |
| Total Equity | 115.58M | 108.54M | 98.02M | 87.2M | 120.14M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 15.2M | 114.08M | 170.83M | 146.07M | 124.16M |
| Total Liabilities | 12.83M | 16.89M | 22.21M | 25.75M | 26.14M |
| Total Equity | 2.36M | 97.19M | 148.62M | 120.32M | 98.02M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -22.48M | -33.1M | -44.78M | -12.28M | -23.59M |
| Investing | 3.89M | 11.25M | 32.01M | 12.64M | -15.56M |
| Financing | 17.8M | 17.58M | 16.86M | -253k | 44.98M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -5.96M | -7.02M | -25.34M | -28.76M | -44.78M |
| Investing | -5.8M | -10.69M | -11.82M | -89.95M | 32.01M |
| Financing | 733k | 104.18M | 76.47M | -983k | 16.86M |
| Market Cap | 241.6M |
| Price to Earnings Ratio | -5.37 |
| Price to Sales Ratio | 53.39 |
| Price to Cash Ratio | 10.74 |
| Price to Book Ratio | 2.37 |
| Dividend Yield | - |
| Shares Outstanding | 28.66M |
| Average Volume (1 week) | 39.11k |
| Average Volume (1 Month) | 26.25k |
| 52 Week Change | 57.28% |
| 52 Week High | 20.00 |
| 52 Week Low | 4.00 |
| Spread (Intraday) | 5.65 (43.93%) |
| Company Name | Nyxoah SA |
| Address |
12 rue edouard belin mont-saint-guibert, walloon brabant 1435 |
| Website | https://www.nyxoah.com |
| Industry | health & allied services,nec (8099) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
